New HIV drugs set to be cheaper

New HIV drugs set to be cheaper

The 1 December listing will substantially reduce the cost of the drugs for patients, which currently retail at $10,800 a year.

The step comes as the Federal Government launches Australia’s eighth national HIV strategy, which aims to virtually eliminate transmission of the virus by 2022.

The TGA approved the once-daily dolutegravir and rilpivirine (Juluca) as a treatment for HIV in July.

https://www.pharmacynews.com.au/news/new-hiv-drugs-set-be-cheaper-0